Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial

BACKGROUND: As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessation moti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, John A. A., Grob, Paul, Kite, Wendy, Williams, Peter, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653992/
https://www.ncbi.nlm.nih.gov/pubmed/29061161
http://dx.doi.org/10.1186/s13104-017-2831-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653992/
https://www.ncbi.nlm.nih.gov/pubmed/29061161
http://dx.doi.org/10.1186/s13104-017-2831-2

Ejemplares similares